BioCryst Pharmaceuticals Non-Current Deferred Revenue (Quarterly) Trends

BioCryst Pharmaceuticals, Inc. (BCRX)

7.09 -0.31 (-4.19%) USD | NASDAQ | Jan 12, 16:00

7.11 +0.02 (+0.28%) Pre-Market: 08:06

View Non-Current Deferred Revenue (Quarterly) for BCRX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Astria Therapeutics, Inc.	--
Hologic, Inc.	Upgrade
Johnson & Johnson	--
Viatris, Inc.	--
KalVista Pharmaceuticals, Inc.	--